1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsMetastatic Breast Cancer Fund is sponsored by TotalAssist. Helps patients pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. Provides instant approval decisions for eligible applicants.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Metastatic breast cancer fund | TotalAssist Get notified when your fund opens Nonprofit patient partners How TotalAssist helps you How financial assistance works What are health equity funds?
Getting started after approval Información en español sobre TotalAssist Approval & getting started For patients, pharmacies, and providers Nonprofit Patient Partner Portal Quick check: application and claim status Patient Advocate Foundation How to support TotalAssist We are currently experiencing high call volume and increased claim volume.
Call wait times are longer than usual and manual claims processing times may also take longer than expected. We apologize for any inconvenience. Please avoid resubmitting duplicate claims as this may further delay processing.
For faster assistance, use your online portal account our ' Quick Search ' tool, live chat, or search help center articles . For non-urgent requests, please submit an inquiry here .
Portal login and quick tools Portal login for nonprofits $4,000 guaranteed award | $7,000 maximum award Help with healthcare costs for metastatic breast cancer This TotalAssist fund helps you pay for out-of-pocket healthcare costs, including medication copays, coinsurance, and deductibles, health insurance premiums, and other expenses. Check your eligibility with our quick and easy tools below.
If this fund is open, apply today for an instant approval decision and use your grant funding right away. Learn how TotalAssist helps you. TotalAssist also offers a breast cancer fund , as well as a breast cancer health equity fund .
Please note that you cannot receive more than one grant for the same condition. To be eligible for this fund, you must: Have a confirmed diagnosis and are in treatment for metastatic breast cancer, or planning to begin treatment in the next 60 days, or have been in treatment in the past 6 months.
This includes active surveillance of a condition Have health insurance that covers your qualifying expenses Have an income at or less than 500% of the Federal Poverty Level, adjusted for your regional Cost of Living Index (COLI). What is this?
Be a legal resident and receive treatment in the U.S. or a U.S. territory Be prescribed a medication or product listed in the approved medications, listed below Quick eligibility checker Answer a few short questions to find out if you might be eligible for this fund.
No documents or personal information needed Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Alzheimer’s disease health equity Ankylosing spondylitis (AS) Basal cell carcinoma (BCC) Biliary tract cancer (BTC) Breast cancer health equity Cancer genetic and genomic testing Chronic inflammatory demyelinating polyneuropathy (CIDP) Chronic kidney disease (CKD) Chronic lymphocytic leukemia (CLL) Chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease (COPD) health equity Chronic spontaneous urticaria (CSU) Coronary artery disease (CAD) health equity Cushing’s disease or syndrome Diabetic macular edema (DME) Diabetic retinopathy (DR) Diffuse large B-cell lymphoma (DLBCL) Duchenne muscular dystrophy (DMD) Eosinophilic granulomatosis with polyangiitis (EGPA) Fabry disease health equity Gastrointestinal stromal tumors (GIST) Gaucher disease health equity Glioblastoma multiforme (GBM) Graft vs host disease (GvHD) Growth hormone deficiency Heart failure (HF) health equity Hemolytic uremic syndrome (HUS) Hepatitis B (HepB) health equity Hepatitis C (HepC) health equity HIV, AIDS, and prevention HIV, AIDS, and prevention health equity Hypertrophic cardiomyopathy Immune thrombocytopenic purpura (ITP) Inflammatory bowel disease (IBD) Inherited retinal disease (IRD) Long-chain fatty acid oxidation disorders (LC-FAOD) Lupus (SLE) health equity Lysosomal acid lipase deficiency (LAL-D) Macular degeneration and related diseases Mantle cell lymphoma (MCL) Metabolic dysfunction-associated steatohepatitis (MASH) Metastatic colorectal cancer Metastatic colorectal cancer health equity Metastatic gastric cancer Metastatic prostate cancer Mucopolysaccharidosis type III (MPS III) Mucopolysaccharidosis type VII (MPS VII) Mucopolysaccharidosis type VII (MPS VII) health equity Multiple myeloma health equity Multiple sclerosis (MS) health equity Myelodysplastic syndromes (MDS) Neuromyelitis optica spectrum disorder (NMOSD) Neurotrophic keratitis (NK) Non-Hodgkin’s lymphoma (NHL) Non-small cell lung cancer (NSCLC) Non-small cell lung cancer (NSCLC) health equity Ovarian cancer health equity Parkinson’s disease health equity Paroxysmal nocturnal hemoglobinuria (PNH) Peripheral vascular and artery disease Philadelphia chromosome negative myeloproliferative neoplasms (MPN) Pompe disease health equity Primary biliary cholangitis (PBC) Prostate cancer health equity Psoriatic arthritis (PsA) Renal cell carcinoma (RCC) Retinal vein occlusion (RVO) Rheumatoid arthritis (RA) Short bowel syndrome (SBS) Small cell lung cancer (SCLC) Social needs assessment & intervention Solid organ transplant preservation and rejection prevention Spinal muscular atrophy (SMA) Spinal muscular atrophy (SMA) health equity Thyroid eye disease (TED) Type 2 diabetes (T2DM) health equity Uterine cancer health equity Virology testing health equity Von Willebrand disease (vWD) Waldenstrom macroglobulinemia Please select a fund to continue.
Please confirm you are in treatment for this condition by a healthcare provider in the U.S. or U.S. territories. Find your medication or treatment: Please select a medication to continue. Do you have [health insurance; government-insured health coverage] that covers the medication or treatment?
If you do not have this coverage, you might not be eligible for this fund. State or territory where you reside: Please select your state. Please enter a valid 5-digit ZIP code.
Estimated current annual income: $ Please enter your estimated annual income. Not sure if you’re eligible for TotalAssist? We encourage you to check your eligibility or complete pre-screening to confirm.
There’s no risk and applying online takes less than 15 minutes. Start your application online or by phone and complete the pre-screening questions to confirm eligibility.
Patient Advocate Foundation covers all the prescription medications for each diagnosis, including generic or bioequivalent drugs, that meet any of the following criteria: FDA-approved, listed in official compendia, and/or listed in published evidence-based or clinical guidelines.
Abraxane (Paclitaxel Protein-Bound) Adriamycin (Doxorubicin Hydrochloride) Afinitor Disperz (Everolimus) Anastrozole (Anastrozole) Capecitabine (Capecitabine) Carboplatin (Carboplatin) Cyclophosphamide (Cyclophosphamide) Datroway (Datopotamab Deruxtecan) DOXIL (Doxorubicin Hcl Pegylated Liposomal) Enhertu (Fam-Trastuzumab Deruxtecan) Epirubicin Hcl (Epirubicin Hydrochloride) Eribulin Mesylate (Eribulin Mesylate) Fluorouracil (Fluorouracil) Frindovyx (Cyclophosphamide) Fulvestrant (Fulvestrant) Gemcitabine Hcl (Gemcitabine) Halaven (Eribulin Mesylate) Herceptin Hylecta (Trastuzumab-Hyaluronidase-Oysk) HERCESSI (Trastuzumab-Strf) Herzuma (Trastuzumab-Pkrb) Inluriyo (Imlunestrant Tosylate) Jemperli (Dostarlimab-Gxly) Kadcyla (Ado-Trastuzumab Emtansine) Kadcyla (Trastuzumab Emtansine) Kanjinti (Trastuzumab-Anns) Kisqali (Ribociclib Succinate) KISQALI FEMARA CO-PACK (Ribociclib And Letrozole) Lapatinib (Lapatinib Ditosylate) Leuprolide Acetate (Leuprolide Acetate) Leuprolide Depot (Leuprolide Acetate) Lupron Depot-Ped (Leuprolide Acetate) Lutrate Depot (Leuprolide Acetate) Margenza (Margetuximab-Cmkb) Megestrol Acetate (Megestrol Acetate) Methotrexate-Nacl (Methotrexate Sodium) Methotrexate Sodium (Methotrexate Sodium) Ogivri (Trastuzumab-Dkst) Ontruzant (Trastuzumab-Dttb) Paclitaxel Protein-Bound (Paclitaxel) Phesgo (Pertuzumab And Trastuzumab-Hy) Soltamox (Tamoxifen Citrate) Talzenna (Talazoparib Tosylate) Tamoxifen Citrate (Tamoxifen Citrate) Tecentriq (Atezolizumab-Hyaluronidase) Trazimera (Trastuzumab-Qyyp) Trodelvy (Sacituzumab Govitecan-Hziy) Tykerb (Lapatinib Ditosylate) Vegzelma (Bevacizumab-Adcd) Zoladex (Goserelin Acetate) Zoledronic Acid (Zoledronic Acid) Metastatic breast cancer (MBC), also known as Stage IV breast cancer and advanced breast cancer, is breast cancer that has spread to the bones.
MBC affects the lymphatic and skeletal systems. C50. 011, C50.
012, C50. 019, C50. 021, C50.
022, C50. 029, C50. 111, C50.
112, C50. 119, C50. 121, C50.
122, C50. 129, C50. 211, C50.
212, C50. 219, C50. 221 … , C50.
222, C50. 229, C50. 311, C50.
312, C50. 319, C50. 321, C50.
322, C50. 329, C50. 411, C50.
412, C50. 419, C50. 421, C50.
422, C50. 429, C50. 511, C50.
512, C50. 519, C50. 521, C50.
522, C50. 529, C50. 611, C50.
612, C50. 619, C50. 621, C50.
622, C50. 629, C50. 811, C50.
812, C50. 819, C50. 821, C50.
822, C50. 829, C50. 911, C50.
912, C50. 919, C50. 921, C50.
922, C50. 929, C50. A0, C50.
A1, C50. A2 Show full list + If your fund is open, apply online 24/7, or call 866-512-3861 , Monday – Friday, 8:30am – 5:30pm ET. Answer pre-screening questions to confirm eligibility.
Have your income, medication, diagnosis, and insurance information ready. Complete the application and get an instant approval decision. You can begin using your grant right away.
Find answers to your questions about applying, claims, grant use, and your portal account. You can use your TotalAssist grant award to help pay for out-of-pocket healthcare expenses. Call us at 866-512-3861 to apply by phone, Monday through Friday, 8:30am - 5:30pm ET.
Connect with other organizations and resources for support. Explore resources beyond TotalAssist Patient Advocate Foundation knows that patients may need support, information, and resources beyond TotalAssist. This can include services like case management, help with living expenses, and much more.
Search our National Financial Resources Directory, find community specific resources, and explore our patient education library.
According to the current listing, eligibility includes: Individuals with a confirmed diagnosis and in treatment for metastatic breast cancer, or planning to begin treatment in the next 60 days, or have been in treatment in the past 6 months (including active surveillance). Confirm the full requirements in the official notice before applying.
The current listing shows $4,000 - $7,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Metastatic Breast Cancer Fund is funded by TotalAssist. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.